Andrew Hykes - 22 Jul 2024 Form 4 Insider Report for Inari Medical, Inc.

Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
22 Jul 2024
Net transactions value
-$165,690
Form type
4
Filing time
24 Jul 2024, 17:04:13 UTC
Previous filing
03 Jul 2024
Next filing
22 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $165,690 -3,000 -0.65% $55.23 455,252 22 Jul 2024 Direct F1, F2
holding NARI Common Stock 1,550 22 Jul 2024 By Child 1
holding NARI Common Stock 1,550 22 Jul 2024 By Child 2
holding NARI Common Stock 1,550 22 Jul 2024 By Child 3
holding NARI Common Stock 1,000 22 Jul 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $54.92 to $55.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.